Maze Therapeutics, Inc. · NASDAQ:MAZE

Coloma Jason V sold 34,501 Maze Therapeutics, Inc. shares (Form 4)

Traded Jul 1, 2026 · Filed Jul 2, 2026

On Jul 1, 2026, Coloma Jason V (Director, Chief Executive Officer) sold 34,501 Maze Therapeutics, Inc. shares at an average US$29.97 for US$1.03M under a trading plan, leaving 287,171 shares. Filed Jul 2, 2026 (Form 4).

Sold
34,501 shares
Price
US$29.97 average (US$29.95 to US$30.44)
Value
US$1.03M
Holding after
287,171 shares (held indirectly)
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Chief Executive Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jul 1, 2026Common StockSale2,593US$29.9823,337Indirect
Jul 1, 2026Common StockSale30,311US$29.95288,768Indirect
Jul 1, 2026Common StockSale1,597US$30.44287,171Indirect

Source

View original at SEC

Related